Please Share:: 
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Equity Buy/Sell (Technical View)
Ø We have covered a whole lot of scrips which can be bought. A few of them continue to be strong, a few have not triggered buy levels and some have reacted slightly. Whenever there is a reaction, we draw your attention to the support levels indicated by us for frontline scrips and invest, esp. in :
o HDFC, HDFC Bank, LIC Hsg Fin., Canara Bk., Bank Baroda , M&M ,
o Ambuja Cement, ACC to name a few.
o Others like Alok Ind., Lupin, ONGC & Sun Pharma > 454 continue to look good.
Ø COMMODITIES :
o Gold has reversed up sharply in trades on 27/04. It looks good to test our target of 23,000.
o Silver similarly has moved up from 66,322 and has touched 72,000 as we write this. It looks set to re-test its all time high of 73,100. We had advised investors to book profits and wait on the sidelines. While the volatility and risk is high at these levels, risk takers who can stomach stops at 66,000 can try longs for a target of 73500-75000.
Have Strict Stop Loss
No comments:
Post a Comment